What Happened?
Shares of dental and medical products company Henry Schein (NASDAQ: HSIC) jumped 2.8% in the afternoon session after the company reported second-quarter 2026 results that surpassed analyst expectations and raised its full-year earnings guidance.
The company's Q2 net sales increased 6.7% year-over-year to $3.46 billion, beating Wall Street's estimates. Its adjusted earnings per share grew 15.5% to $1.27, also ahead of the consensus. This top-line growth was supported by a 4.6% increase in organic revenue, a key metric that reflects internal sales growth. Following the strong performance, Henry Schein slightly lifted its 2026 outlook for adjusted earnings per share to a midpoint of $5.34. The better-than-expected quarter and improved forecast signaled confidence in the company's operational performance, driving investor optimism.
The shares closed the day at $89.02, up 2.9% from the previous close.
Is now the time to buy Henry Schein? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Henry Schein’s shares are not very volatile and have only had 3 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 12 months ago when the stock dropped 9.7% on the news that the company reported second-quarter earnings that missed profit expectations and showed a year-over-year decline. The healthcare products distributor posted an adjusted earnings per share of $1.10, which fell short of analyst forecasts and decreased 10.6% compared to the prior year. While revenues of $3.24 billion slightly beat estimates, investors appeared concerned with the company's shrinking profitability. The results stemmed from softer demand for its dental products in the United States. Furthermore, the company's net income dropped to $86 million from $104 million in the same period last year. Despite the weak quarterly performance, Henry Schein reaffirmed its full-year guidance for 2025.
Henry Schein is up 16% since the beginning of the year, and at $89.10 per share, it has set a new 52-week high. Investors who bought $1,000 worth of Henry Schein’s shares 5 years ago would now be looking at an investment worth $1,153.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
